CA2723352A1 - Dispositif de mesure et de gestion d'un analyte et procedes associes - Google Patents

Dispositif de mesure et de gestion d'un analyte et procedes associes Download PDF

Info

Publication number: CA2723352A1
Authority: CA; Canada
Prior art keywords: therapeutic agent; analyte measurement; recommended; user; analyte
Prior art date: 2008-05-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2723352A

Other languages

English (en)

Inventor

Zara Sieh

David Horwitz

David Price

Peter Krulevitch

Donna Savage

Robert Sharlte

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

LifeScan Inc

Original Assignee

LifeScan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-05-07

Filing date

2009-05-07

Publication date

2009-11-12

2009-04-03 Priority claimed from US12/417,875 external-priority patent/US20100256047A1/en

2009-05-07 Application filed by LifeScan Inc filed Critical LifeScan Inc

2009-11-12 Publication of CA2723352A1 publication Critical patent/CA2723352A1/fr

Status Abandoned legal-status Critical Current

Links

239000012491 analyte Substances 0.000 title claims abstract description 232
238000005259 measurement Methods 0.000 title claims abstract description 216
238000000034 method Methods 0.000 title claims abstract description 147
239000003814 drug Substances 0.000 claims abstract description 194
229940124597 therapeutic agent Drugs 0.000 claims abstract description 188
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 65
238000007726 management method Methods 0.000 claims abstract description 38
102000004877 Insulin Human genes 0.000 claims abstract description 33
108090001061 Insulin Proteins 0.000 claims abstract description 33
229940125396 insulin Drugs 0.000 claims abstract description 32
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 25
239000008103 glucose Substances 0.000 claims abstract description 25
239000008280 blood Substances 0.000 claims abstract description 23
210000004369 blood Anatomy 0.000 claims abstract description 23
230000001225 therapeutic effect Effects 0.000 claims abstract description 17
238000004891 communication Methods 0.000 claims abstract description 13
230000000007 visual effect Effects 0.000 claims abstract description 13
210000001124 body fluid Anatomy 0.000 claims abstract description 7
238000001514 detection method Methods 0.000 claims abstract description 4
235000012054 meals Nutrition 0.000 claims description 11
239000003795 chemical substances by application Substances 0.000 claims description 6
229940079593 drug Drugs 0.000 claims description 4
238000004364 calculation method Methods 0.000 claims description 3
230000002503 metabolic effect Effects 0.000 claims description 3
238000001794 hormone therapy Methods 0.000 claims description 2
230000001172 regenerating effect Effects 0.000 claims description 2
238000002483 medication Methods 0.000 claims 1
230000003213 activating effect Effects 0.000 description 17
238000012360 testing method Methods 0.000 description 16
230000006870 function Effects 0.000 description 15
230000036541 health Effects 0.000 description 14
230000000977 initiatory effect Effects 0.000 description 13
235000021152 breakfast Nutrition 0.000 description 9
235000011888 snacks Nutrition 0.000 description 9
230000002354 daily effect Effects 0.000 description 7
230000003442 weekly effect Effects 0.000 description 6
102000016261 Long-Acting Insulin Human genes 0.000 description 5
108010092217 Long-Acting Insulin Proteins 0.000 description 5
229940100066 Long-acting insulin Drugs 0.000 description 5
238000012790 confirmation Methods 0.000 description 5
238000010586 diagram Methods 0.000 description 5
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
108010026951 Short-Acting Insulin Proteins 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
102000001554 Hemoglobins Human genes 0.000 description 2
108010054147 Hemoglobins Proteins 0.000 description 2
229940123958 Short-acting insulin Drugs 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000003203 everyday effect Effects 0.000 description 2
230000002641 glycemic effect Effects 0.000 description 2
229940127560 insulin pen Drugs 0.000 description 2
230000003993 interaction Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000004448 titration Methods 0.000 description 2
238000012549 training Methods 0.000 description 2
KJLPSBMDOIVXSN-UHFFFAOYSA-N 4-[4-[2-[4-(3,4-dicarboxyphenoxy)phenyl]propan-2-yl]phenoxy]phthalic acid Chemical compound C=1C=C(OC=2C=C(C(C(O)=O)=CC=2)C(O)=O)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 KJLPSBMDOIVXSN-UHFFFAOYSA-N 0.000 description 1
102100025101 GATA-type zinc finger protein 1 Human genes 0.000 description 1
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
229940123452 Rapid-acting insulin Drugs 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
235000006694 eating habits Nutrition 0.000 description 1
230000037406 food intake Effects 0.000 description 1
235000012631 food intake Nutrition 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000004026 insulin derivative Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
229940127017 oral antidiabetic Drugs 0.000 description 1
239000003538 oral antidiabetic agent Substances 0.000 description 1
229920001690 polydopamine Polymers 0.000 description 1
230000008569 process Effects 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Physics & Mathematics (AREA)
Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Biophysics (AREA)
Pathology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Emergency Medicine (AREA)
Optics & Photonics (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

CA2723352A 2008-05-07 2009-05-07 Dispositif de mesure et de gestion d'un analyte et procedes associes Abandoned CA2723352A1 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US5125808P	2008-05-07	2008-05-07
US61/051,258		2008-05-07
US12/417,875 US20100256047A1 (en)	2009-04-03	2009-04-03	Analyte Measurement and Management Device and Associated Methods
US12/417,875		2009-04-03
PCT/US2009/043125 WO2009137661A1 (fr)	2008-05-07	2009-05-07	Dispositif de mesure et de gestion d'un analyte et procédés associés

Publications (1)

Publication Number	Publication Date
CA2723352A1 true CA2723352A1 (fr)	2009-11-12

Family

ID=40848756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2723352A Abandoned CA2723352A1 (fr)	2008-05-07	2009-05-07	Dispositif de mesure et de gestion d'un analyte et procedes associes

Country Status (9)

Country	Link
EP (1)	EP2320787A1 (fr)
JP (1)	JP2011523478A (fr)
KR (1)	KR20110014176A (fr)
CN (1)	CN102088898A (fr)
AU (1)	AU2009244268A1 (fr)
BR (1)	BRPI0912210A2 (fr)
CA (1)	CA2723352A1 (fr)
IL (1)	IL208710A0 (fr)
WO (1)	WO2009137661A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2037999B1 (fr)	2006-07-07	2016-12-28	Proteus Digital Health, Inc.	Système d'administration parentérale intelligent
US9125979B2 (en)	2007-10-25	2015-09-08	Proteus Digital Health, Inc.	Fluid transfer port information system
WO2009067463A1 (fr)	2007-11-19	2009-05-28	Proteus Biomedical, Inc.	Dispositifs d'évaluation de structures de transport de fluides associées au corps
BR112012007134A2 (pt)	2009-09-29	2016-08-23	Lifescan Scotland Ltd	dispositivo e método de teste de analito para controle de diabetes
AU2011207314B2 (en) *	2010-01-22	2015-04-02	Lifescan, Inc.	Analyte testing method and system
RU2587795C2 (ru)	2010-02-01	2016-06-20	Проутьюс Диджитал Хэлс, Инк.	Система сбора данных
EP2531096A4 (fr)	2010-02-01	2013-09-11	Proteus Digital Health Inc	Système de collecte de données par les deux poignets
CN102770868B (zh)	2010-02-25	2017-02-22	生命扫描苏格兰有限公司	具有高低血糖趋势通知的分析物测试方法和系统
JP5423932B1 (ja) *	2012-07-02	2014-02-19	コニカミノルタ株式会社	黄疸計および黄疸計の出力方法
CN110404140B (zh)	2013-01-29	2022-09-30	赛诺菲-安万特德国有限公司	电子模块和药物输送装置
WO2017096511A1 (fr) *	2015-12-07	2017-06-15	香港商台北市生活智能科技有限公司	Système d'obtention automatique d'un enregistrement de traitement
WO2017166292A1 (fr) *	2016-04-01	2017-10-05	创新精密仪器有限公司	Appareil portable de gestion de médicament
EP3559837B1 (fr) *	2016-12-23	2024-07-03	Sanofi-Aventis Deutschland GmbH	Soutenir le contrôle sanitaire
WO2018115316A1 (fr)	2016-12-23	2018-06-28	Sanofi-Aventis Deutschland Gmbh	Unité de gestion de données pour prendre en charge le suivi de santé
WO2018153648A1 (fr) *	2017-02-23	2018-08-30	Novo Nordisk A/S	Systèmes et procédés permettant de communiquer une dose
JP7393413B2 (ja) *	2018-07-26	2023-12-06	サノフイ	医薬品用量を調節する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4002408A (en)	1971-10-14	1977-01-11	Gakken Co. Ltd.	System and device for overhead projection
US20030208113A1 (en)	2001-07-18	2003-11-06	Mault James R	Closed loop glycemic index system
JP2003099529A (ja) *	2001-09-25	2003-04-04	Dainippon Screen Mfg Co Ltd	医療用携帯情報端末および医療行為管理方法
GB0127989D0 (en) *	2001-11-22	2002-01-16	Glaxo Group Ltd	Medicament dispensing system
JP2004000555A (ja) *	2002-04-25	2004-01-08	Matsushita Electric Ind Co Ltd	投薬量決定支援装置、注射器および健康管理支援システム
GB2389419B (en) *	2002-06-05	2006-02-22	Diabetes Diagnostics Inc	Analyte testing device
JP2004024699A (ja) *	2002-06-27	2004-01-29	Asahi Medical Co Ltd	血糖管理システム、血糖管理プログラム、装着システムおよび血糖管理方法
CA2511746C (fr) *	2003-11-06	2013-03-26	Lifescan, Inc.	Stylo d'administration de medicament a organe de notification d'evenement
US20070033074A1 (en) *	2005-06-03	2007-02-08	Medtronic Minimed, Inc.	Therapy management system
JP4943728B2 (ja) *	2006-03-30	2012-05-30	テルモ株式会社	血糖計

2009
- 2009-05-07 CA CA2723352A patent/CA2723352A1/fr not_active Abandoned
- 2009-05-07 AU AU2009244268A patent/AU2009244268A1/en not_active Abandoned
- 2009-05-07 WO PCT/US2009/043125 patent/WO2009137661A1/fr not_active Ceased
- 2009-05-07 KR KR1020107027094A patent/KR20110014176A/ko not_active Ceased
- 2009-05-07 BR BRPI0912210A patent/BRPI0912210A2/pt not_active Application Discontinuation
- 2009-05-07 CN CN2009801270772A patent/CN102088898A/zh active Pending
- 2009-05-07 EP EP09743647A patent/EP2320787A1/fr not_active Withdrawn
- 2009-05-07 JP JP2011508659A patent/JP2011523478A/ja active Pending
2010
- 2010-10-14 IL IL208710A patent/IL208710A0/en unknown

Also Published As

Publication number	Publication date
BRPI0912210A2 (pt)	2016-09-06
IL208710A0 (en)	2010-12-30
KR20110014176A (ko)	2011-02-10
AU2009244268A1 (en)	2009-11-12
EP2320787A1 (fr)	2011-05-18
JP2011523478A (ja)	2011-08-11
CN102088898A (zh)	2011-06-08
WO2009137661A1 (fr)	2009-11-12

Publication	Publication Date	Title
US20100256047A1 (en)	2010-10-07	Analyte Measurement and Management Device and Associated Methods
US20100016700A1 (en)	2010-01-21	Analyte measurement and management device and associated methods
CA2723352A1 (fr)	2009-11-12	Dispositif de mesure et de gestion d'un analyte et procedes associes
JP6461885B2 (ja)	2019-01-30	糖尿病管理のための分析物試験方法及びデバイス
JP4157031B2 (ja)	2008-09-24	二つの携帯型医療装置間の無線データ情報を制御する方法とシステム
EP2710502B1 (fr)	2018-12-12	Recueillement de données dynamique
US20130172710A1 (en)	2013-07-04	Handheld Diabetes Manager With A Personal Data Module
EP3973855A1 (fr)	2022-03-30	Procédés de test d'analyte et dispositif de calcul de thérapie d'insuline basale
JP2015530889A (ja)	2015-10-29	糖尿病患者のための高血糖又は低血糖を示す方法及びシステム
CN105324070A (zh)	2016-02-10	针对患有糖尿病的人的低血糖治疗
AU2015200504A1 (en)	2015-02-19	Analyte measurement and management device and associated methods
HK1188311A (en)	2014-04-25	Updatability of structured blood glucose tests on handheld diabetes management devices
HK1188311B (en)	2018-01-19	Updatability of structured blood glucose tests on handheld diabetes management devices
HK1194649A (en)	2014-10-24	Analyte testing method and device for diabetes management
HK1194649B (en)	2018-04-20	Analyte testing method and device for diabetes management
HK1189787A (en)	2014-06-20	Analyte testing method and device for diabetes management

Legal Events

Date	Code	Title	Description
2014-05-13	EEER	Examination request	Effective date: 20140506
2017-07-06	FZDE	Discontinued	Effective date: 20170525